Combination tablet integrating rifaximin, a non-absorbable rifamycin, with metronidazole for gastrointestinal bacterial overgrowth and infections. Produced by combo drug formulators, traded through international pharma networks to importers, and acquired by hospital and retail buyers for targeted therapy in digestive health